| 논문분류 | 춘계학술대회 초록집 |
|---|---|
| 제목 | Renal Cell Carcinoma Associated with Xp 11.2 Translocation in Autosomal Dominant Polycystic Kidney Disease |
| 저자 | Hyuk Huh1, Hayne Cho Park1, Young Hwan Hwang2, Mi Yeun Han1, Hyun Suk Kim1,Jeong Yeon Cho1, Kyung Chul Moon1, Hyeon Hoe Kim1, Curie Ahn1 |
| 출판정보 | 2013; 2013(1): |
| 키워드 | 상염색체 우성 다낭성 신질환, Xp11.2전좌 연관 신장암/Renal cell carcinoma associated with Xp 11.2 translocation |
| 초록 | Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary cystic disease. Although the underlying pathophysiology is unclear, the prevalence of renal cell carcinoma (RCC) has been reported to be higher in ADPKD cohort than general population. Regarding that somatic mutations are identified in ADPKD patients during lifetime, it is reasonable to think that somatic mutation may cause renal cell carcinoma in some cases. This is the first case report of Xp11.2 translocation RCC in an ADPKD patient. A 38-year-old woman with ADPKD was admitted for lipoma resection on October 2004. 10×11 cm sized cystic lesion with inner septation and well enhancing solid portion was incidentally detected in her right kidney upper pole by abdominal computed tomography (CT). The cystic mass was followed up by biennial abdominal CT or ultrasonogram and found to be stable without the change of morphology or size until January 2011. Then, however, the size of cystic mass was increased from 10×11 cm to 10× 12 cm, and lymph node enlargement was newly found in the retrocaval and aortocaval areas. Cyst aspiration and cytologic examination did not show malignant cells. After 6 months, the size of cystic mass was even more increased to 10.7×12.7 in abdominal CT. On October 2011, we decided to perform diagnostic and therapeutic right radical nephrectomy. Microscopic examination of the right kidney revealed RCC containing clear cell components with strong transcription factor E3 (TFE3) expression by immunohistochemistry. The fluorescence in situ hybridization exam confirmed the diagnosis of Xp 11.2 translocation RCC by showing break-apart signal in TFE3 gene. Shortly after the diagnosis, multiple metastatic lesions were detected in lung and she started systemic chemotherapy. In general, Xp 11.2 translocation RCC is reported to appear in the childhood and shows female preponderance. However, this case suggests that somatic mutation in the adulthood may lead to the development of Xp 11.2 translocation RCC and change the clinical manifestation of renal mass dynamically in ADPKD patients. Since Xp 11.2 translocation RCC has an aggressive clinical course and poor prognosis, clinicians need to aware it when the cystic mass changes its behavior or size in ADPKD. |
| 원문(PDF) | PDF 원문보기 |